Gaboxadol hydrochloride
Gaboxadol hydrochloride is a chemical compound developed by Merck Group for use in pharmaceutical research and development. It functions as a selective agonist of the GABAA receptor, which plays a role in the inhibitory neurotransmission in the central nervous system. The compound is utilized in various in vitro and in vivo laboratory studies to investigate the effects of GABAA receptor modulation.
Lab products found in correlation
4 protocols using gaboxadol hydrochloride
Preparation and Administration of Neuroactive Steroids
Cocaine and Gaboxadol Hydrochloride Experiments
Gaboxadol-Enriched Paraquat Exposure
Selective Modulation of GABA Receptor Subtypes
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!